Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma
about
Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control studyIron: a target for the management of Kaposi's sarcoma?The DNA helicase-primase complex as a target for herpes viral infectionHuman herpesvirus 8 seropositivity among sexually active adults in UgandaCommunication between the active sites and dimer interface of a herpesvirus protease revealed by a transition-state inhibitor.Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa.Molecular biology of KSHV in relation to AIDS-associated oncogenesis.Epidemiology and genetic variability of HHV-8/KSHV in Pygmy and Bantu populations in Cameroon.Early and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells.BALB/c mice immunized with a combination of virus-like particles incorporating Kaposi sarcoma-associated herpesvirus (KSHV) envelope glycoproteins gpK8.1, gB, and gH/gL induced comparable serum neutralizing antibody activity to UV-inactivated KSHV.Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt"Non-detection of human herpesvirus 8 (HHV-8) DNA in HHV-8-seropositive blood donors from three Brazilian regions.Human herpesvirus 8 serological markers and viral load in patients with AIDS-associated Kaposi's sarcoma in Central African Republic.Sex and geographic patterns of human herpesvirus 8 infection in a nationally representative populationābased sample in Uganda.Epidemiology and transmission of Kaposi's sarcoma-associated herpesvirus.Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic areaModulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors.Seroprevalence and determinants of human herpes virus 8 infection in adult Nigerians with and without HIV-1 infection.Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women.Paediatric oncology in the Queen Elizabeth Hospital, BlantyreAIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa.Atypical Kaposi Sarcoma of the Tongue in HIV Positive Tanzanian FemaleEarly childhood infection of Kaposi's sarcoma-associated herpesvirus in Zambian households: a molecular analysisTransmission of human herpesvirus type 8 infection within families in american indigenous populations from the Brazilian Amazon.Professional antigen presenting cells in human herpesvirus 8 infection.A population-based study of Kaposi Sarcoma-associated herpesvirus seropositivity in Uganda using principal components analysis.Development of an immunofluorescence assay using recombinant proteins expressed in insect cells to screen and confirm presence of human herpesvirus 8-specific antibodies.Seroprevalence and risk factors for human herpesvirus 8 infection, rural EgyptRisk factors for seropositivity to Kaposi sarcoma-associated herpesvirus among children in UgandaPopulation-based assessment of kaposi sarcoma-associated herpesvirus DNA in plasma among UgandansSeroprevalence of human herpesvirus-8 in HIV-1 infected and uninfected individuals in CameroonA Review of Human Herpesvirus 8, the Kaposi's Sarcoma-Associated Herpesvirus, in the Pediatric PopulationProspects of a novel vaccination strategy for human gamma-herpesviruses.The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma.High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population.Association between transfusion with human herpesvirus 8 antibody-positive blood and subsequent mortality.No Evidence of Human Herpesvirus 8 among Iranian Patients Infected with HIV.Successful treatment of bacillary angiomatosis with oral doxycycline in an HIV-infected child with skin lesions mimicking Kaposi sarcoma.Was Kaposi's sarcoma-associated herpesvirus introduced into China via the ancient Silk Road? An evolutionary perspective.Effects of Antiretroviral Therapy on Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Transmission Among HIV-Infected Zambian Children.
P2860
Q24804288-0CD0FD2E-9024-48F9-9276-42C3ADD03758Q24807119-74A820AB-5500-477C-8E77-B1E7C482079FQ26849412-8453334D-B35F-43A2-B955-AB35E81CED98Q28743392-345748F1-7580-48DA-8ABA-59349CD02A5AQ33202465-1F2F3C70-46E0-4192-95E1-8DB025E6F597Q33360459-8A897FFA-4970-4EE7-BE0D-B54A1BA1C369Q33560572-9CBA75F8-A792-41E3-A64A-DACAA6EB6844Q33618403-410FF831-D0C6-4E11-AF5B-2BB06BE443AEQ33623056-64F5B808-B094-4C41-A906-BA275F334AE1Q33798426-555299E4-D4B8-44C3-81BF-553C31039D90Q33952679-6998CBF4-5031-43FF-8483-674DC8340EBBQ33999780-BDF0FDBB-1F85-4976-86C5-4857334DAAADQ34042277-E7542276-417D-42E3-9B51-B851CAA6E34DQ34172766-D10631BA-9F14-42BA-96A3-0B6AF06928E2Q34446582-37308A9B-EA2F-419D-A726-AF0161D46F85Q34783313-4F97FC74-77CD-4A8E-A2CB-8D6B6349B8B1Q35158385-DEF67382-E938-4EEF-BE82-48852DFB2820Q35171944-988E0C70-4D8C-4F09-90C3-ABC03B03F5E5Q35397565-C50BC969-FB92-4C7C-8460-61E45739BA28Q35938273-E0EC055C-E916-44AC-8B85-0C95016677BFQ36268446-D479CF92-D7C1-48A1-B04A-EB4DF3A4B61DQ36333092-4851CD43-4094-412D-9C6C-64164C5D8FB1Q36504540-55F59BED-6899-4301-B2B1-1A9E4A8CA3FCQ36507059-E97F6C2B-289E-46BB-8F6E-C581F84553E0Q36546999-1295F936-2CED-4457-9713-D3FD870E905CQ36689882-9E029303-8B06-4EC8-A1F0-68CAFA1BA633Q36844879-E4425CB3-EEC9-4AA4-82B7-0EC6B1ED0927Q36944934-F89B6A7F-845D-4153-B66F-E0A15ACCC8E9Q37000339-F65BA4EB-8C5F-44CB-B460-213E75536EABQ37128291-3139815C-6B5E-4D21-A568-CB6A999CED62Q37235307-583F10B1-453F-47AE-BD36-F4D2A0D4126DQ37600164-542B2396-0FE5-4D62-AED0-1181855455CFQ37780705-DDDEB1A4-9CDC-451C-918C-D5344651C31FQ38248404-12A53396-6E83-4FFD-94D8-6025A53E028EQ38860797-E51C2885-1B16-439C-B36C-B01A23269377Q38867266-A8AA89E3-89A6-4E49-ADC1-EC36003D0ABFQ39496400-4F030C9D-A876-4E66-AF78-2D91FB7793D3Q39561026-58C05073-B8C2-4E92-9C78-F71768753099Q40131205-207FBD19-6AC0-4C48-9753-E76163086DCDQ40725718-47E56E08-EB0C-4A01-A9F0-E14F9714B665
P2860
Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma
description
2003 nĆ® lÅ«n-bĆ»n
@nan
2003 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« Õ
ÕøÖÕ¶ÕøÖÕ”ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2003 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ°ÕøÖÕ¶Õ¾Õ”ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2003幓ć®č«ę
@ja
2003幓č«ę
@yue
2003幓č«ę
@zh-hant
2003幓č«ę
@zh-hk
2003幓č«ę
@zh-mo
2003幓č«ę
@zh-tw
2003幓č®ŗę
@wuu
name
Review of the distribution of ...... incidence of Kaposi's sarcoma
@ast
Review of the distribution of ...... incidence of Kaposi's sarcoma
@en
type
label
Review of the distribution of ...... incidence of Kaposi's sarcoma
@ast
Review of the distribution of ...... incidence of Kaposi's sarcoma
@en
prefLabel
Review of the distribution of ...... incidence of Kaposi's sarcoma
@ast
Review of the distribution of ...... incidence of Kaposi's sarcoma
@en
P2860
P921
P356
P1476
Review of the distribution of ...... incidence of Kaposi's sarcoma
@en
P2093
P2860
P2888
P356
10.1038/SJ.BJC.6600745
P407
P577
2003-01-01T00:00:00Z
2003-01-13T00:00:00Z